Spreadex Market Update
Large-cap stocks made gains shortly after the open
Equity markets, however, pared losses as soon as the news became understood to have little material impact on prices. Shares recovered in Europe to close out the day around one per cent higher on average.
The age of high frequency trading and market making makes reaction to this type of news brutally fast. Often otders have been filled before every participant knows what happened. Traders brave enough to offer liquidity at the bottom have been rewarded so far. But their luck could run out.
Risers:
InterContinental Hotels
UBS upgrades InterContinental Hotels Group to buy from neutral and raises its price target to 2200p from 2050p. Notes an improvement on a number of its concerns as well as recent share price weakness.
Marks & Spencer
HSBC upgrades Marks & Spencer to overweight from neutral and target to 550p from 490p. Says M&S is the most operationally geared to play on the UK consumer recovery compared to peers.
easyJet
Despite shares being dragged lower yesterday by Ryanair’s profit warning, Low-cost airline easyJet have announced a 4% rise in passenger numbers to more than 6.1 million. They receive a broker upgrade to buy from add with price target of 1600p at Numis Securities.
Dixons
Dixons was the top 250 riser after announcing in line earnings but will be disposing any unprofitable units as UK sales gain. They are close to exiting its online unit PIXmania and have agreed to sell its Turkish operations to help enable it to focus on UK growth.
ICAP
Morgan Stanley raises ICAP to overweight from underweight and lifts its target price to 418p from 283p. Says despite expected near-term seasonal weakness, curve steepening and the likelihood of increased volatility increases positive earnings revision risk. With two thirds of revenues derived from rates/FX, ICAP is the most geared to play cyclical improvements, it adds
SuperGroup
The British company behind Superdry fashion brand have announced group sales in the first three months of the year had jumped by a quarter and that it was confident of meeting full-year expectations. The interim management statement showed total group sales for the quarter rose 25.7% to £75 million.
Go-Ahead
The provider of passenger transport Thursday posted a 10.25 drop in pre-tax profit during the full year-end, the overall results are slightly ahead of the board's expectations and the company is progressing well towards its bus operating
Communisis
The provider of personalized customer communication services have acquired the entire share capital of Editions Publishing Ltd, a content marketing agency in the financial services sector on a cash free, debt free basis of 5.87 million pounds
Fallers
GlaxoSmithKline
Pharmaceutical giant GlaxoSmithKline PLC (GSK) said Thursday its cancer drug MAGE-A3 didn't meet the first co-primary endpoint in the Phase III melanoma trial, but the trial will continue until the second co-primary endpoint is assessed.
Melrose Industries
UBS downgrades Melrose Industries to neutral from buy and lifts its target price to 305p from 300p. Notes the stock has reached its target price, with improved margin guidance from the Elster acquisition coming faster than expected. Says the group is now trading at a 10% premium to the sector, which is beginning to feel like a stretch.
Lamprell
Nomura downgrades European oil services to bearish from neutral. Says a slower rate of global capex growth and lower returns on projects suggests consensus 2014 EPS need to come down by up to 15%. Lamprell cut to reduce from Neutral by Nomura.
It's easy to open an account
- Fill in our simple online application form
- Fund your account
- Start trading the global markets instantly!
SEARCH FOR AN ARTICLE:
Enter a keyword and search for all relevant articlesMARKET ANALYSIS
RECENT POSTS
DISCLAIMER
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.
Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.
No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.
The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.